A 2005 study, which used LPR-Tag LADY transgenic PCa mice models, showed that FOXA1 was differentially expressed in prostate diseases, with upregulation in both pre-neoplastic lesions and adenocarcinomas [19]. Here, FOXA1 is linked to adenocarcinoma.